Literature DB >> 22001133

Cushing's disease: results of treatment and factors affecting outcome.

Ariachery C Ammini1, Saptarshi Bhattacharya, Jaya Praksh Sahoo, Jim Philip, Nikhil Tandon, Ravinder Goswami, Viveka J Jyotsna, Rajesh Khadgawat, Sunil Chumber, Aashu Seth, Asis K Karak, Bhawani S Sharma, Poodipedi Sarat Chandra, Ashish Suri, Manish S Sharma, Shashank S Kale, Manmohan Singh.   

Abstract

OBJECTIVE: To analyze the therapeutic results of intervention and the factors affecting the outcome of patients with Cushing's disease (CD) cared for at the All Indian Institute of Medical Science (AIIMS), New Delhi.
DESIGN: Patients with Cushing's disease treated at a teritiary care centre from January 2000 to December 2009 were prospectively studied.
RESULTS: Ninety-seven patients received treatment for CD during this period. Mean duration of follow-up was 3.4 ± 2.2 (mean ± SD) years. Eighty-one patients (83.5%) underwent transsphenoidal surgery (TSS) as the primary treatment modality. Fifty-four patients (66.7%) went into remission after initial TSS; ten (18.5%) of them relapsed after a mean follow-up period of 2.9 ± 2.1 (mean ± SD) years. Histopathologic examination of resected tissue showed corticotroph adenoma in 48 of the 54 (88.9%) who went into remission and 17 of the 27 (63.0%) who did not go into remission after the initial TSS. Sixteen patients with severe hypercortisolism underwent bilateral adrenalectomy (BA) as a life-saving measure which was followed by pituitary surgery 6 to 12 months later. Five patients including one with a large macroadenoma required three or more procedures to achieve eucortisolism.
CONCLUSION: Fifty-four out of 81 (66.7%) of our patients with CD had remission following initial TSS, ten of whom relapsed later on. Sixteen patients unerwent BA as a life-saving procedure. Factors affecting outcome were, age, gender, low dose dexamethasone suppression test cortisol value and histologic confirmation of corticotroph adenoma.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22001133     DOI: 10.14310/horm.2002.1312

Source DB:  PubMed          Journal:  Hormones (Athens)        ISSN: 1109-3099            Impact factor:   2.885


  7 in total

Review 1.  The Treatment of Cushing's Disease.

Authors:  Rosario Pivonello; Monica De Leo; Alessia Cozzolino; Annamaria Colao
Journal:  Endocr Rev       Date:  2015-06-11       Impact factor: 19.871

Review 2.  The experience with transsphenoidal surgery and its importance to outcomes.

Authors:  Jürgen Honegger; Florian Grimm
Journal:  Pituitary       Date:  2018-10       Impact factor: 4.107

3.  Negative correlation between tumour size and cortisol/ACTH ratios in patients with Cushing's disease harbouring microadenomas or macroadenomas.

Authors:  M C Machado; A E E Alcantara; A C L Pereira; V A S Cescato; N R Castro Musolino; B B de Mendonça; M D Bronstein; M C B V Fragoso
Journal:  J Endocrinol Invest       Date:  2016-06-30       Impact factor: 4.256

4.  Role of bilateral adrenalectomy in adrenocorticotropic hormone-dependent Cushing's syndrome.

Authors:  V P Jyotsna
Journal:  Indian J Endocrinol Metab       Date:  2015 Sep-Oct

5.  Duration of post-operative hypocortisolism predicts sustained remission after pituitary surgery for Cushing's disease.

Authors:  Prachi Bansal; Anurag Lila; Manjunath Goroshi; Swati Jadhav; Nilesh Lomte; Kunal Thakkar; Atul Goel; Abhidha Shah; Shilpa Sankhe; Naina Goel; Neelam Jaguste; Tushar Bandgar; Nalini Shah
Journal:  Endocr Connect       Date:  2017-09-14       Impact factor: 3.335

6.  Endoscopic vs. microscopic transsphenoidal surgery for Cushing's disease: a systematic review and meta-analysis.

Authors:  Leonie H A Broersen; Nienke R Biermasz; Wouter R van Furth; Friso de Vries; Marco J T Verstegen; Olaf M Dekkers; Alberto M Pereira
Journal:  Pituitary       Date:  2018-10       Impact factor: 4.107

7.  Etiology and clinical profile of patients with Cushing's syndrome: A single center experience.

Authors:  Ariacherry C Ammini; Nikhil Tandon; Nandita Gupta; Ashu Seith Bhalla; Kandaswamy Devasenaspathy; Guresh Kumar; Jaiprakash P Sahoo; Sachin Chittawar; Jim Philip; Manas P Baruah; C S Dwarakanath; Sudhir Tripathi
Journal:  Indian J Endocrinol Metab       Date:  2014-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.